GLP-1 agonists like Ozempic, Trulicity, Mounjaro, Victoza, Wegovy started as a way to treat diabetes but have since become popular for weight loss.
A study on GLP1RA medications found that behavioral side effects likely do not result from direct action on GLP1R.